Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
Abstract Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed to investigate the protective effect...
Guardado en:
Autores principales: | Lei Yu, Xue-ke Zhao, Ming-liang Cheng, Guo-zhen Yang, Bi Wang, Hua-juan Liu, Ya-xin Hu, Li-li Zhu, Shuai Zhang, Zi-wen Xiao, Yong-mei Liu, Bao-fang Zhang, Mao Mu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2011379de5de4b26a8cdaf3193191911 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
por: Daiqiong Fang, et al.
Publicado: (2017) -
EFFICACY OF SACCHAROMYCES BOULARDII IN THE MANAGEMENT OF ACUTE WATERY DIARRHEA
por: Misbah Munir, et al.
Publicado: (2021) -
Saccharomyces boulardii modulates oxidative stress and renin angiotensin system attenuating diabetes-induced liver injury in mice
por: Leticia Barssotti, et al.
Publicado: (2021) -
ACTIVIDAD DE DISTINTAS PRESENTACIONES COMERCIALES DE SACCHAROMYCES BOULARDII
por: Acevedo G.,Claudia, et al.
Publicado: (2004) -
Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
por: Indu Khatri, et al.
Publicado: (2017)